Stockreport

Evaxion Announces Closing of $15 Million Public Offering

Evaxion Biotech A/S - American Depositary Share  (EVAX) 
PDF COPENHAGEN, Denmark, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing i [Read more]